Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
BiVictriX Therapeutics PLC
BVXCurrent price
10 GBX
0 GBX (0.00%)
Last closed
8.5 GBX
Company
www.bivictrix.com
ISIN
GB00BNXH3K91
Sector
Healthcare
Industry
Biotechnology
Exchange
London Exchange
Capitalization
8 269 892 GBX
Yield for 12 month
-28.57 %
1Y
3Y
5Y
10Y
15Y
BVX
BiVictriX Therapeutics plc, a biotechnology company, engages in the research and experimental development of pharmaceutical products in the United Kingdom. The company develops Bi-Cygni, a proprietary platform that combines the discovery of novel, cancer-selective twin-antigen pairs or fingerprints with bispecific antibody engineering insights to create anti-cancer therapeutics. Its lead program is BVX001, a first-in-class Bi Cygni antibody drug conjugates to treat acute myeloid leukemia. The company also develops BVX002 for treating ovarian and other solid tumors; and BVX003 for bladder and other solid tumors. The company was formerly known as BiVictriX plc and changed its name to BiVictriX Therapeutics plc in August 2021. BiVictriX Therapeutics plc was founded in 2016 and is headquartered in Macclesfield, the United Kingdom. Address: Mereside, Macclesfield, United Kingdom, SK10 4TG
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5 011.09 GBXP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-16 534 470 GBX
Last Year
-15 131 592 GBX
Current Quarter
-9 018 822 GBX
Last Quarter
-8 918 601 GBX
Key Figures BVX
1 year
3 years
5 years
10 years
EBITDA
-3 176 651 GBX
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-62.99 %
PEG Ratio
–
Return On Equity TTM
-103.99 %
Wall Street Target Price
5 011.09 GBX
Revenue TTM
–
Book Value
0.028 GBX
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
-522 089 GBX
Earnings per share
-0.04 GBX
Diluted Eps TTM
-0.04 GBX
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics BVX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BVX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation BVX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-2.4546
Price Book MRQ
3.5803
Financials BVX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BVX
For 52 weeks
7.01 GBX
14.28 GBX
50 Day MA
10.93 GBX
Shares Short Prior Month
–
200 Day MA
10.76 GBX
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart